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A B S T R A C T
In the present study the glycosylation pattern of the middle ear mucosa (MEM) of guinea pigs, an
approved model for middle ear research, was characterized with the purpose to identify bioadhesive
ligands which might prolong the contact time of drug delivery systems with the middle ear mucosa
(MEM). To assess the utility of ﬁve ﬂuorescein labeled plant lectins with different carbohydrate
speciﬁcities as bioadhesive ligands, viable MEM specimens were incubated at 4 C and the lectin binding
capacities were calculated from the MEM-associated relative ﬂuorescence intensities. Among all lectins
under investigation, ﬂuorescein-labeled wheat germ agglutinin (F-WGA) emerged as the highest
bioadhesive lectin. In general, the accessibility of carbohydrate moieties of the MEM followed the order:
sialic acid and N-acetyl-D-glucosamine (WGA) >>mannose and galactosamine (Lens culinaris aggluti-
nin) >N-acetyl-D-glucosamine (Solanum tuberosum agglutinin) > fucose (Ulex europaeus isoagglutinin
I) >> terminal mannose a-(1,3)-mannose (Galanthus nivalis agglutinin). Competitive inhibition studies
with the corresponding carbohydrate revealed that F-WGA-binding was inhibited up to 90% conﬁrming
speciﬁcity of the F-WGA–MEM interaction. The cilia of the MEM were identiﬁed as F-WGA binding sites
by ﬂuorescence imaging as well as a z-stack of overlays of transmission, F-WGA- and nuclei-stained
images of the MEM. Additionally, co-localisation experiments revealed that F-WGA bound to acidic
mucopolysaccharides of the MEM. All in all, lectin-mediated bioadhesion to the MEM is proposed as a
new concept for drug delivery to prolong the residence time of the drug in the tympanic cavity especially
for successful therapy for difﬁcult-to-treat diseases such as otitis media.
ã 2015 Published by Elsevier B.V.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
1. Introduction
Otitis media (OM) is one of the most common inﬂammatory
diseases of children and therefore the third most common reason
for antibiotic therapy in pediatrics (Holstiege et al., 2013).
Although speciﬁc antibiotics are administered, the overall clinical
effectiveness is limited due to low penetration of the drug to the
middle ear mucosa (MEM) (Coates et al., 2008), inaccessibility of
the bacteria within the grown bioﬁlm (Post et al., 2004) as well as
low symptomatic amendment within the ﬁrst 24h (Glasziou et al.,
2004; Rovers et al., 2006). To increase the therapeutic outcome and
to prolong the contact time of the drug with the infected tissue
drug loaded formulations such as thermosensitive hydrogels (Lee
et al., 2004; Li et al., 2014; Honeder et al., 2014), ototopical drops
(Kutz et al., 2013), implants (Goycoolea et al., 1992; Goycoolea and
Muchow, 1994; Nether et al., 2004), micropumps (Lehner et al.,
1997), intranasal drug delivery systems (Chandrasekhar and
Mautone, 2004), coated middle ear prostheses (Lensing et al.,
2013; Ehlert et al., 2013; Hesse et al., 2013), and pellets (Daniel
et al., 2012) were developed. Although there are many different
therapeutic approaches, a local intratympanic therapy seems to be
most beneﬁcial for the treatment of OMas a decrease in side effects
provoked by systemic therapy as well as an increase in compliance
of the young patients will be expected. Nevertheless, the local
intratympanic therapy is limited by unfavorable anatomical
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conditions. The nasopharynx is connected with the tympanic
cavity that can lead to rapid drainage of intratympanally
administered solutions and suspensions. To avoid Eustachian
drainage and to concurrently prolong the contact time of the drug
we propose bioadhesive carrier systems interactingwith theMEM.
As the middle ear is lined with a modiﬁed respiratory epithelial
layer (Hentzer, 1984) and comprises, among others, ciliated,
secretory as well as goblet cells (Lim and Shimada, 1972), the
carbohydrates of the glycocalyx at the membrane of these cells
might be exploited as bioadhesive sites for glycotargeted delivery.
Carbohydrate-binding proteins such as plant lectins interacting
with certain sugar residues on the cell surface can function as a
ligand. This bioadhesion concept of lectin-mediated targeting has
been already reported for overcoming several biological barriers
(Bies et al., 2004; Wirth et al., 2002), such as the intestinal
epithelium (Gabor et al., 1998), the urothelium (Plattner et al.,
2008; Neutsch et al., 2013), the blood–brain barrier (Plattner et al.,
2010), and the lymphoid tissue (Diesner et al., 2012).
As a ﬁrst step toward putting this concept into practice the
glycosylation pattern of theMEMhas to be elucidated, which is not
reported until now to the best of our knowledge. To identify
accessible carbohydrate moieties and vice versa appropriate
bioadhesive ligands, the interaction of MEM isolated from guinea
pigs with a panel of ﬂuorescent labeled lectins with different
carbohydrate speciﬁcities was investigated: the wheat germ
agglutinin (WGA) from Triticum vulgare binding to N-acetyl-D-
glucosamine and sialic acid (Goldstein and Poretz,1986), the lectin
from furze seeds (Ulex europaeus isoagglutinin I, UEA-I) which
interacts with a-L-fucose-containing carbohydrates (Gürtler,
1978), the a-1,3-mannose-speciﬁc Galanthus nivalis agglutinin
(GNA) (Van Damme et al., 1987), the Solanum tuberosum lectin
(STA) from potato tubers binding toN-acetyl-D-glucosamine (Allen
and Neuberger,1973), and the lentil lectin from Lens culinaris (LCA)
recognizing galactosaminyl-/mannosyl-residues (Flika et al.,1978).
Ongoing from cytoadhesion experiments at 4 C and cytoinvasion
assays at 37 C, the speciﬁcity of interaction will be described.
Additionally, co-localisation of lectin-interacting carbohydrates
and acidic mucopolysaccharides was applied to identify the lectin
binding sites at the MEM.
All in all, this study is aimed to roughly characterize the
carbohydrate pattern of the MEM and to identify ligands for
glycotargeting as a basis for the development of bioadhesive
antibiotic formulations.
2. Materials and methods
2.1. Materials
The ﬂuorescein-labeled lectins from T. vulgare (WGA; wheat
germ agglutinin, molar ratio ﬂuorescein/protein (F/P) = 4.5),
S. tuberosum (STA; F/P = 3.0), U. europaeus (UEA-I, isoagglutinin I;
F/P =2.9), G. nivalis (GNA; F/P = 5.5), and Lens culinaris (LCA;
F/P =3.4) were purchased from Vector Laboratories (Burlingame,
CA, USA). Hoechst 33342 trihydrochloride trihydrate was obtained
from Invitrogen (Vienna, Austria). Alcian blue and N,N0,N0 0-
triacetyl-chitotriose were from Sigma–Aldrich (Vienna, Austria).
Fluorescein-labeled a-lactalbumin was acquired from Molecular
Probes (Eugene, Oregon, USA). All other chemicals were bought
from Sigma–Aldrich and were of analytical grade.
2.2. Lectin-binding capacity of the MEM
Immediately after sacriﬁcing the guinea pig the bullas were
dissected and opened carefully. After rinsing the MEM with 0.9%
NaCl the bullas were mounted with the auditory canal upside and
the mucosa was incubated with 500ml solution of ﬂuorescein-
labeled lectins (500pmol/ml 0.9% NaCl) for 30min at 4 C or 37 C.
Unbound lectin was removed by washing the cell layer 5 times
with 500ml saline and the nuclei were stained by incubation with
500ml solution of Hoechst 33342 (0.1mg/ml 0.9% NaCl) for 10min
at 37 C. The specimen was washed again thoroughly and the
staining pattern of the MEM was ﬁxed by incubation in ice-cold
MeOH at20 C for 20min. After rehydration in 0.9% NaCl at room
temperature for another 20min, the MEM was carefully removed
from the bulla and mounted on a slide in FluorSaveTM for
visualization and quantiﬁcation. To allow comparability of the
data, different issues were considered for calculation: (i) since the
degree of ﬂuorescein-substitution differs between the lectins, the
MFI of each lectin was related to an apparent conjugation number
of 1mol ﬂuorescein per mol lectin according to the ﬂuorescein/
protein ratio. (ii) As the size of the specimens is different and
sometimes parts of the collected MEM were overlapping, the
highest MFI of squares with stained nuclei was set 100% and only
squares were considered with a MFI higher than the autoﬂuor-
escence of the cells. (iii) Only the MFI of cell-associated lectins of
nuclei positive squares was considered, related to the MFI of the
stained nuclei in these squares, and expressed as a percentage.
As a control to estimate nonspeciﬁc binding, samples prepared
as described above were treated with a solution of F-lactalbumin
instead of the lectins.
2.3. Speciﬁcity of lectin-binding
To investigate the speciﬁcity of the F-WGA–cell interaction
competitive inhibition experiments using the complementary
carbohydrate N,N0,N0 0-triacetyl-chitotriose were performed. After
washing the bulla with 0.9% NaCl the MEM was incubated with a
freshly prepared mixture of 250ml solution of the complementary
carbohydrate (0–500nmol/ml) and 250ml solution of F-WGA
(500pmol/ml) for 30min at 4 C. After removal of non-bound
lectin and soluble carbohydrate–lectin complexes by thorough
washings and preparation of theMEM, the cell-bound ﬂuorescence
was determined as described below.
2.4. Lectin-uptake by the MEM
In order to ﬁnd out, whether the MEM-bound lectin is taken up
into the cells, a pulse-chase protocol was performed: theMEMwas
incubated with 500ml solution of ﬂuorescein-labeled lectins
(500pmol/ml 0.9% NaCl) for 30min at 4 C followed by removal
of unbound lectin by washing 5 times with saline. The cell-bound
lectins were allowed to be internalized during the chase period at
37 C for another 60min. Subsequently, the mean MEM-associated
ﬂuorescence intensity (MFI) was determined as described below.
2.5. Staining of acidic components of the mucosa
After ﬁxing the ear with the auditory canal in an upright
position, the bulla was ﬁlled with 500ml 3% acetic acid and
incubated for 3min. This solution was replaced by 500ml alcian
blue solution (10mg/ml in 3% acetic acid) and removed after
30min incubation at room temperature (Sheehan and Hrapchak,
1980; Bancroft and Stevens, 1982). The MEM was washed 5 times
with aqueous 0.9% NaCl solution and after staining with F-WGA as
described above the lectin binding capacity was visualized by
microscopy.
2.6. Semi-quantitative determination of ﬂuorescence intensity
The relative cell-layer-associated ﬂuorescence intensity of the
ﬂuorescein-labeled lectins and the Hoechst 33342 stained nuclei
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was determined by reading the ﬂuorescence (TECAN, Inﬁnite
M200, Austria) at an excitation/emission wavelength of 485/
525nm and 365/450nm, respectively. The slides were ﬁxed in a
frame and the laser was adjusted to read one 33mm square after
another throughout the whole area of the ﬁxed slide. Cell-layers
incubated with buffer served as a control for autoﬂuorescence of
cells and slides.
To guarantee comparability of the results and to consider the
inﬂuence of uneven and sometimes folded surfaces on the
quantum yield, the MFI of the nuclei stained with Hoechst
33342 was chosen as a measure for the amount of tissue in each
sample. The ﬂuorescein-readouts were related to this area and
expressed as a percentage.
2.7. Microscopy
To visualize adhesion of the different lectins to the MEM,
ﬂuorescence images of the prepared slideswere acquired at 20 or
63 magniﬁcation with a Zeiss Axio Observer.Z1 microscopy
system equipped with the LED illumination system “Colybri”
(Zeiss, Göttingen, Germany). For comparability of the images, the
excitation exposure time of each lectin was related to an apparent
conjugation number of 1mol ﬂuorescein per mol of lectin by
considering the F/P-ratio.
Histological images were obtained using a Nikon Eclipse 50i
microscope equipped with an EXFO X-Cite 120 ﬂuorescence
illumination system (Nikon, Germany). The images of the FITC-
labeled lectins at an excitation/emission wavelength of 465–495/
515–555nm as well as the transmitted light images were acquired
at 40magniﬁcation and processed using Lucia G v5.0 software for
evaluation.
2.8. Statistics
The integrated analysis tools of Microsoft Excel1 were used to
carry out statistical analyses. The hypothesis test was made by
comparing twomeans from independent samples, among twodata
sets (t-test). Values of p<0.05 were considered as signiﬁcant. All
experiments were performed at least three times.
3. Results
To guarantee that the upcoming experiments are performed
with viable MEM cells different preparation techniques were
tested in preliminary assays using propidium iodide staining of
nuclei as a selection criterion (data not shown). In general,
incubation in presence of PBS resulted in immediate loss of
viability up to 80%. Additionally, detachment of the MEM from the
bone matrix followed by incubation with ligands yielded non-
utilizable specimens due to folding of the tissue and uneven
staining. Only incubation of the bone attached mucosa in presence
of saline at 4 C or 37 C and subsequent isolation of the MEM just
before analysis yielded reliable results with more than 90% viable
cells.
3.1. Lectin-binding capacity
Preliminary studies were aimed at selection of appropriate
concentration ranges for the lectin binding studies.Whereas F-WGA
seemed to over-saturate the MEM-specimens at concentrations
higher than 1000pmol/ml, 500pmol/ml were still sufﬁcient to
saturate potential binding sites. Thus this concentrationwas applied
to investigate the glycosylationpatternof theMEMfromguineapigs
byuse ofﬁveﬂuorescein-labeled lectinswithdifferent carbohydrate
speciﬁcities.
Upon incubation at 4 CWGA exhibited the highest binding rate
with 2.320.6% MFI and F-GNA the lowest one close to the
autoﬂuorescence of the MEM (Fig. 1A). The intensity of the other
lectins was similar amounting to about 0.5%MFI, so that the MEM-
associated ﬂuorescence intensities followed the order: WGA>>
LCA> STA>UEA-I >>GNA. Besides, the interaction of WGA and all
other lectins as well as that between GNL and UEA-I, STA as well as
LCA was signiﬁcantly different (p<0.05). At 37 C the highest
MEM-association capacity was again observed in case of WGA
amounting to 2.550.7% MFI (Fig. 1B). Nevertheless, this
interaction was only signiﬁcantly different to that of GNA. At the
mean, some places changed in the ranking in comparison to 4 C
resulting in the following order: WGA>UEA-I > STA> LCA>GNA.
3.2. Microscopical visualization of the binding pattern
The microscopic visualization of the lectin-MEM interaction
conﬁrmed the results of the quantitative assay at both temper-
atures as the MFI of the images decreased according to the ranking
described above (Fig. 2). Interestingly, differences in the staining
pattern were observed: the N-acetyl-D-glucosamine interacting
lectins WGA and STA yielded colored clusters but only WGA
showed additional less intense as well as diffuse staining. LCA
was rather evenly distributed throughout the MEM-surface and
UEA-I-binding was lowest but still visible. In contrast, the binding
of GNA could not be observed microscopically.
As WGA proved to highly interact with the MEM, this
interaction was elucidated in more detail. The overlay of
differential interference contrast (DIC) images and ﬂuorescence
images revealed that the WGA-binding pattern coincides with the
ciliated cell surface (Fig. 3). Although the exposure time was
extended to 3 s binding of F-LCA and F-GNA to ciliated areas was
not detectable. To get some further evidence for WGA-binding to
the cilia, a z-stack of imageswas collected. At the level of the nuclei
(Fig. 4A) no ﬂuorescence of boundWGAwas observed. Moving the
focus plane 6mmhigher toward the apical face (Fig. 4B), the nuclei
were still visible and a rather weak scattered diffuse ﬂuorescence
of WGA was detectable. Analyzing the image acquired another
6mmhigher revealed diffuse blue ﬂuorescence but a sharp F-WGA
staining of ﬁnger-like structures of the MEM (Fig. 4C), which
disappeared again by further rising the focus plane (Fig. 4D). This
conﬁrms that WGA predominantly interacts with protruding
elements of the MEM such as the cilia. Additionally, as displayed
in Fig. 5, co-localization of acidic glycans and the binding site of
WGA by co-staining with alcian blue and F-WGA revealed a
punctuate pattern on the MEM indicative for acidic polysacchar-
ides as lectin binding sites on the cilia of the MEM.
3.3. Speciﬁcity of the lectin-binding
Contribution of non-speciﬁc protein–protein interactions to the
lectin–MEM interaction was investigated by binding studies with
F-lactalbumin (Permyakov, 2005). Even in presence of high
amounts of lactalbumin up to 2000pmol/ml, no interaction could
be detected. Similarly, the double amount of ﬂuorescein as
contained in the highest concentration of F-WGA applied
contributed only to 0.02% of MFI.
As only WGA considerably interacted with the mucosa, the
speciﬁcity of the interaction was elucidated by competitive
inhibition of lectin binding sites at the mucosa by addition of
the best ﬁtting complementary carbohydrate N,N0,N0 0-triacetyl-
chitotriose. The MFI of MEM-bound WGA decreased with
increasing amounts of the corresponding carbohydrate up to
90% (Fig. 6). The values were signiﬁcantly different (p<0.05) and
conﬁrm high speciﬁcity of the WGA–MEM interaction since the
adhesion was inhibited by a deﬁned molecule.
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[(Fig._2)TD$FIG]
Fig. 2. Microscopical visualization and comparison of the lectin binding pattern and intensity of F-WGA (A), F-LCA (B), F-STA (C) and F-UEA-I (D) after incubation at 4 C by
overlaying ﬂuorescence and DIC images. For comparability, the exposure time was correlated to the F/P-ratio of the lectins. Images were acquired at 20 magniﬁcation.
[(Fig._1)TD$FIG]
Fig. 1. Association of lectins with the MEM at 4 C (A) or 37 C (B). For comparability, the cell-associated ﬂuorescein intensity was related to an apparent F/P-ratio of 1 as well
as to the ﬂuorescence intensity of stained nuclei (mean SD, n =3).
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[(Fig._5)TD$FIG]
Fig. 5. Co-staining of the acidic mucopolysaccharides with alcian blue (A) and sialyl- as well as N-acetyl-glucosaminyl residues with F-WGA (B) of the MEM. Images were
acquired at 40 magniﬁcation.
[(Fig._3)TD$FIG]
Fig. 3. Identiﬁcation of cilia as a binding site for WGA by ﬂuorescence imaging (A) DIC-imaging (B) and overlay of both (C). Images were acquired at 63 magniﬁcation.
[(Fig._4)TD$FIG]
Fig. 4. Z-stack of DIC (1), nuclei (2, stained blue) and F-WGA (3, green) at different levels of theMEM: 0mm(A), 6mm(B),12mm(C) and 18mm(D). Imageswere acquiredwith
63 magniﬁcation. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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3.4. Uptake of WGA into MEM-cells
According to the observation that the meanMFI of MEM-bound
WGAwas slightly, but not signiﬁcantly, higher at 37 C than at 4C
the lectin might be bound and taken up into the cell. For that
purpose,ﬁrst, the lectinwas bound to the cell-membrane at 4 C. At
this temperature the ﬂuidity of the cell membrane and the
metabolism is reduced and energy consuming mechanisms like
active transport are repressed. After removal of non-bound lectin,
the cells were incubated in a second step at 37 C to allow for
energy dependent uptake processes. Due to shielding of the
ﬂuorescence of internalized ligand, the MFI is expected to
decrease. Although the MFI was 2.320.6% after incubation at
4 C and decreased to 1.710.6% after incubation at 37 C for
60min, again the differences were not signiﬁcant (data not
shown). Thus, internalization ofmembrane-associated lectin could
not be conﬁrmed.
4. Discussion
In an effort to identify bioadhesive or even cytoinvasive ligands
for improved drug delivery in the middle ear, the glycosylation
pattern of the MEM from guinea pigs, an approved model for
research of OM (Zak and Sande, 1999), was systematically
characterized via detailed analysis of the binding capacities of
selected ﬂuorescein-labeled lectins with different carbohydrate
binding speciﬁcities.
For quantitation of the lectin-binding rate and comparability
of results, the ﬂuorescein density of the lectins as well as
the ﬂuorescein intensity of stained nuclei as a measure for the
tissue were considered for calculation. According to the results,
the glycocalyx of the MEM contains highest numbers of accessible
sialic acid and N-acetyl-D-glucosamine moieties and minor
amounts of fucosyl- or mannosyl-residues. In case of 37 C,
however, the glycosylation pattern changed following the order:
sialic acid and N-acetyl-D-glucosamine > fucose >N-acetyl-D-glu-
cosamine >mannose and galactosamine> terminal mannose
a-(1,3)-mannose. The different glycosylation pattern at the two
temperatures might be due to temperature-dependent viscosity of
the mucus (Snary et al., 1973) which seems to inﬂuence the
accessibility of the carbohydrate residues. At body temperature the
MEM contains about 3.17-fold higher amounts of fucose and
terminal mannose a-(1,3)-mannose as well as 1.73-fold more
N-acetyl-D-glucosamine residues. The amounts of sialic acid and
N-acetyl-D-glucosamine or mannose and galactosamine moieties
were comparable with those at 4 C increasing only 1.10- and 1.15-
fold, respectively. Since both, WGA and STA interact with N-acetyl-
D-glucosamine, butWGA additionallywith sialic acid, the 3.27-fold
higher binding rate of WGA is indicative for presence of high
amounts of sialyl-residues. This observation was additionally
conﬁrmed microscopically by co-localisation of WGA binding sites
and acidic mucopolysaccharides.
For drug delivery to themiddle ear not only the binding rate but
also the speciﬁcity of the interaction is another important
parameter. According to competitive inhibition studies WGA
speciﬁcally interacted with the MEM as indicated by up to 90%
inhibition. Additionally, non-speciﬁc protein–protein interactions
negligibly contribute to lectin–MEM binding. Out of these reasons
WGA is an interesting ligand for a lectin-mediated drug delivery to
the middle ear. Although the MFI of WGA decreases by 25% only at
the mean by increasing the temperature from 4 C to 37 C,
cytoinvasion of the bioadhesive ligand could not be conﬁrmed. It
should be considered, however, that in case of OM the drug should
preferably interact after local administration in the tympanic
cavity with the cause of disease, the bacteria. Nevertheless, uptake
into the MEM-cells might be beneﬁcial to combat also bacteria
hidden in the cytoplasm.
The quantitation of lectin binding-efﬁciency is conﬁrmed
qualitatively by ﬂuorescence microscopy revealing the sialyl-
and N-acetyl-D-glucosamine speciﬁc WGA as the most efﬁcient
ligand. According to the literature, the composition of the
glycocalyx is altered during OM due to upregulation of mucin
genes (Ohashi et al., 1989). Since mucin genes encode among
others for sialic acid (Lin et al., 2001), the number of potential
WGA-binding sites might increase even in case of inﬂammation
and improve the residence time in the tympanic cavity and the
efﬁciency of WGA-grafted formulations.
Histologically, the MEM consists of epithelial-, secretory- and
goblet cells, whereas the luminal intratympanic face additionally
contains ciliated areas without nuclei (Hentzer, 1984). Applying
double staining techniques, those cilia of the MEM surface are
identiﬁed as a binding site forWGA. This aspectmight be beneﬁcial
for lectin-mediated drug delivery since mucociliary clearance
might decrease the efﬁcacy of non-adhesive formulations.
However, according to the literature the ciliary motion is
diminished (Ogasawara et al., 2007) during inﬂammation and
might not inﬂuence the lectin–MEM interaction.
Another aspect to be considered for use of WGA-functionalized
carrier systems for OM-therapy is the formation of a bioﬁlm
consisting of bacteria, which overlays the MEM (Post et al., 2004).
Consequently, the bioﬁlm can limit accessibility of the MEM and
block the docking sites for WGA so that the carrier cannot interact.
However, former studies demonstrate that the bioﬁlm is stained
with WGA (Thornton et al., 2013). Thus, even the bioﬁlm might be
an additional potential bioadhesive site for WGA-grafted drug
delivery systems for therapy of OM.
5. Conclusion
All in all, the screening of the glycosylation pattern of the MEM
by use of lectins with different carbohydrate speciﬁcity revealed
that sialic acid and N-acetyl-D-glucosamine are the most abundant
and accessible binding sites of the MEM. Consequently, among the
lectins under investigation, WGA emerged as the most promising
ligand for drug carrier systems interacting with the cilia of the
MEM. Thus, the concept of lectin-mediated bioadhesive drug
delivery is proposed as a platform for local intratympanic therapy,
which offers prolonged residence time, shortened diffusional
pathways and increased concentration gradient that altogether
should result in improved efﬁcacy of drugs.
[(Fig._6)TD$FIG]
Fig. 6. Competitive inhibition ofWGA-binding to theMEMbyaddition of increasing
amounts of the complementary carbohydrate.
E. Engleder et al. / International Journal of Pharmaceutics 484 (2015) 124–130 129
Acknowledgement
This study was supported by the Austrian Science Fund (FWF
grant P 24260-B19).
References
Allen, A.K., Neuberger, A., 1973. The puriﬁcation and properties of the lectin from
potato tubers, a hydroxproline-containing glycoprotein. Biochem. J. 135, 307–
314.
Bancroft, J., Stevens, A.,1982. Theory and Practice of Histological Techniques, 2nd ed.
Churchill Livingstone, New York, pp. 194–198.
Bies, C., Lehr, C.M., Woodley, J.F., 2004. Lectin-mediated drug targeting: history and
applications. Adv. Drug Deliv. Rev. 56, 425–435.
Chandrasekhar, S.S., Mautone, A.J., 2004. Otitis media: treatment with intranasal
aerosolized surfactant. Laryngoscope 114, 472–485.
Coates, H., Thornton, R., Langlands, J., Filion, P., Keil, A.D., Vijayasekaran, S.,
Richmond, P., 2008. The role of chronic infection in children with otitis media
with effusion: evidence for intracellular persistence of bacteria. Otolaryngol.
Head Neck Surg. 138, 778–781.
Daniel, M., Chessman, R., Al-Zahid, S., Richards, B., Rahman, C., Ashraf, W., McLaren,
J., Cox, H., Qutachi, O., Fortnum, H., Fergie, N., Shakesheff, K., Birchall, J.P.,
Bayston, R.R., 2012. Bioﬁlm eradication with biodegradable modiﬁed-release
antibiotic pellets. Arch. Otolaryngol. Head Neck Surg. 138, 942–949.
Diesner, S.C., Wang, X.Y., Jensen-Jarolim, E., Untersmayr, E., Gabor, F., 2012. Use of
lectin-functionalized particles for oral immunotherapy. Ther. Deliv. 3, 277–290.
Ehlert, N., Mueller, P.P., Stieve, M., Lenarz, T., Behrens, P., 2013. Mesoporous silica
ﬁlms as a novel biomaterial: applications in the middle ear. Chem. Soc. Rev. 42,
3847–3861.
Flika, K., Coupek, J., Kocourek, J., 1978. Studies on lectins. XL. O-glycosyl derivatives
of spheron in afﬁnity chromatography of lectins. Biochim. Biophys. Acta 539,
518–528.
Gürtler, L.G., 1978. The fucosyl speciﬁc lectins of Ulex europaeus and Sarothamnus
scoparius. Biochemical characteristics and binding properties to human B-
lymphocytes. Biochim. Biophys. Acta 544, 593–604.
Gabor, F., Stangl, M., Wirth, M., 1998. Lectin-mediated bioadhesion: binding
characteristics of plant lectins on the enterocyte-like cell lines Caco-2 HT-
29 and HCT-8. J. Control. Release 55, 131–142.
Glasziou, P.P., Del Mar, C.B., Sanders, S.L., Hayem, M., 2004. Antibiotics for acute
otitis media in children. Cochrane Database Syst. Rev. 1:CD000219.
Goldstein, I.J., Poretz, R.D., 1986. Isolation, physiocochemical characterization and
carbohydrate-binding speciﬁcity of lectins. In: Liener, I.E., Sharon, N., Goldstein,
L.J. (Eds.), The Lectins: Properties, Functions, and Applications in Biology and
Medicine. Academic Press, Orlando, USA, pp. 33–247.
Goycoolea, M.V., Muchow, D.D., 1994. Sustained release of antimicrobials in the
middle ear using a biodegradable support. Ann. Otol. Rhinol. Laryngol. Suppl.
163, 46–48.
Goycoolea, M.V., Muchow, D.D., Sirvio, L.M.,Winandy, R.M., Canafax, D.M., Hueb, M.,
1992. Extended middle ear drug delivery: a new concept; a new device. Acta.
Otolaryngol. Suppl. 493, 119–126.
Hentzer, E., 1984. Ultrastructure of themiddle ear mucosa. Acta. Otolaryngol. Suppl.
414, 19–27.
Hesse, D., Badar, M., Bleich, A., Smoczek, A., Glage, S., Kieke,M., Behrens, P., Müller, P.
P., Esser, K.H., Stieve, M., Prenzler, N.K., 2013. Layered double hydroxides as
efﬁcient drug delivery system of ciproﬂoxacin in the middle ear: an animal
study in rabbits. J. Mater. Sci. Mater. Med. 24, 129–136.
Holstiege, J., Schink, T., Molokhia, M., Mazzaglia, G., Innocenti, F., Oteri, A., Bezemer,
I., Poluzzi, E., Puccini, A., Ulrichsen, S.P., Sturkenboom, M.C., Triﬁrò, G., Garbe, E.,
2013. Systemic antibiotic use among children and adolescents in germany: a
population-based study. Eur. J. Pediatr. 172, 787–795.
Honeder, C., Engleder, E., Schöpper, H., Gabor, F., Reznicek, G., Wagenblast, J.,
Gstoettner, W., Arnoldner, C., 2014. Sustained release of triamcinolone
acetonide from an intratympanically applied hydrogel designed for the delivery
of high glucocorticoid doses. Audiol. Neutrootol. 9, 193–202.
Kutz Jr., J.W., Roland, P.S., Lee, K.H., 2013. Ciproﬂoxacin 0.3% +dexamethasone 0:1%
for the treatment for otitis media. Expert Opin. Pharmacother. 14, 2399–2405.
Lee, S.H., Lee, J.E., Baek, W.Y., Lim, J.O., 2004. Regional delivery of vancomycin using
pluronic F-127 to inhibit methicillin resistant Staphylococcus aureus (MRSA)
growth in chronic otitis media in vitro and in vivo. J. Control. Release 96, 1–7.
Lehner, R., Brugger, H., Maassen, M.M., Zenner, H.P., 1997. A totally implantable drug
delivery system for local therapy of the middle and inner ear. Ear Nose Throat J.
76, 567–570.
Lensing, R., Bleich, A., Smoczek, A., Glage, S., Ehlert, N., Luessenhop, T., Behrens, P.,
Müller, P.P., Kietzmann, M., Stieve, M., 2013. Efﬁcacy of nanoporous silica
coatings onmiddle ear prostheses as a delivery system for antibiotics: an animal
study in rabbits. Acta Biomater. 9, 4815–4825.
Li, C., Gu, J., Mao, X., Ao, H., Yang, X., 2014. Preparation of levoﬂoxacin thermo-
sensitive gel and clinical application in the treatment of suppurative otitis
media. Acta Otolaryngol. 134, 468–474.
Lim, D.J., Shimada, T., 1972. Distribution of ciliated cells in the human middle ear:
electron and light microscopic observations. Ann. Otol. Rhinol. Laryngol. 81,
203–211.
Lin, J., Tsuprun, V., Kawano, H., Paparella, M.M., Zhang, Z., Anway, R., Ho, S.B., 2001.
Characterization of mucins in human middle ear and eustachian tube. Am. J.
Physiol. Lung Cell. Mol. Physiol. 280, L1157–L1167.
Nether, A., Nagl, M., Prieskorn, D., Mitchell, A., Brown, N., Schrott-Fischer, A., Miller,
J., 2004. Tolerability of N-chlorotaurine in the guinea pig middle ear: a pilot
study using an improved application system. Ann. Otol. Rhinol. Laryngol. 113,
76–81.
Neutsch, L., Wambacher, M., Wirth, E.M., Spijker, S., Kählig, H., Wirth, M., Gabor, F.,
2013. UPEC biomimickry at the urothelial barrier: lectin-functionalized PLGA
microparticles for improved intravesical chemotherapy? Int. J. Pharm. 450,163–
176.
Ogasawara, Y., Namai, T., Yoshino, F., Lee, M.C., Ishii, K., 2007. Sialic acid is an
essential moiety of mucin as a hydroxyl radical scavenger. FEBS Lett. 581, 2473–
2477.
Ohashi, Y., Nakai, Y., Furuya, H., Esaki, Y., Ikeoka, H., Kato, S., Kato, M., 1989.
Mucociliary disease of the middle ear during experimental otitis media with
effusion induced by bacterial endotoxin. Ann. Otol. Rhinol. Laryngol. 98, 479–
484.
Permyakov, E.A., 2005. a-Lactalbumin. Nova Science Publishers Inc., New York, pp.
82–86.
Plattner, V.E., Wagner, M., Ratzinger, G., Gabor, F., Wirth, M., 2008. Targeted drug
delivery: binding and uptake of plant lectins using human 5637 bladder cancer
cells. Eur. J. Pharm. Biopharm. 70, 572–576.
Plattner, V.E., Germann, B., Neuhaus, W., Noe, C.R., Gabor, F., Wirth, M., 2010.
Characterization of two blood-brain barriermimicking cell lines: distribution of
lectin-binding sites and perspectives for drug delivery? Int. J. Pharm. 387, 34–41.
Post, J.C., Stoodley, P., Hall-Stoodley, L., Ehrlich, G.D., 2004. The role of bioﬁlms in
otolaryngologic infections. Curr. Opin. Otolaryngol. Head Neck Surg. 12, 185–
190.
Rovers,M.M., Glasziou, P., Appelman, C.L., Burke, P., McCormick, D.P., Damoiseaux, R.
A., Gaboury, I., Little, P., Hoes, A.W., 2006. Antibiotics for acute otitis media: a
meta-Analysis with individual patient data. Lancet 368, 1429–1435.
Sheehan, D., Hrapchak, B., 1980. Theory and Practice of Histotechnology, 2nd ed.
Battelle Press, Ohio pp. 163, 173–174.
Snary, D., Allen, A., Pain, R.H., 1973. The effect of temperature on gel formation in
pig-gastric mucus. Eur J. Biochem. 36, 72–75.
Thornton, R.B., Wiertsema, S.P., Kirkham, L.A., Rigby, P.J., Vijayasekaran, S., Coates, H.
L., Richmond, P.C., 2013. Neutrophil extracellular traps and bacterial bioﬁlms in
middle ear effusion of children with recurrent acute otitis media – a potential
treatment target. PLoS One 8, e53837.
Van Damme, E.J.M., Allen, A.K., Peumans, W.J., 1987. Isolation and characterization
of a lectin with exclusive speciﬁcity towards mannose from snowdrop
(Galanthus nivalis) bulbs. FEBS Lett. 215, 140–144.
Wirth, M., Gerhardt, K., Wurm, C., Gabor, F., 2002. Lectin-mediated drug delivery:
inﬂuence of mucin on cytoadhesion of plant lectins in vitro? J. Control. Release
79, 183–191.
Zak, O., Sande, M.A.,1999. Handbook of AnimalModels of Infection. Academic Press,
London, UK, pp. 403–408.
130 E. Engleder et al. / International Journal of Pharmaceutics 484 (2015) 124–130
